167 related articles for article (PubMed ID: 23052636)
61. [Influence of pre-transplant serum level of soluble CD30 on the long-term survival rates of kidney transplant recipients and grafts].
Chen JH; Lü R; Chen Y; Wu JY; He Q; Huang HF; Qu LH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1560-3. PubMed ID: 16179119
[TBL] [Abstract][Full Text] [Related]
62. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
[TBL] [Abstract][Full Text] [Related]
63. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Ostrowska J; Gralak B; Majchrzak J
Transplant Proc; 2006; 38(1):86-9. PubMed ID: 16504671
[TBL] [Abstract][Full Text] [Related]
64. Soluble CD30 correlates with clinical but not subclinical renal allograft rejection.
Hirt-Minkowski P; Roth M; Hönger G; Amico P; Hopfer H; Schaub S
Transpl Int; 2013 Jan; 26(1):75-83. PubMed ID: 23137306
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection.
Mahmoud K; Opelz G; Pelzl S; Daniel V; Sommerer C; Zeier M; Schmidt J; Schönemann C; Schnülle P; Süsal C
Transplantation; 2007 Apr; 83(8):1035-40. PubMed ID: 17452892
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of soluble CD30 as an immunologic marker in heart transplant recipients.
Spiridon C; Hunt J; Mack M; Rosenthal J; Anderson A; Eichhorn E; Magee M; Dewey T; Currier M; Nikaein A
Transplant Proc; 2006 Dec; 38(10):3689-91. PubMed ID: 17175368
[TBL] [Abstract][Full Text] [Related]
67. Posttransplant sCD30 as a biomarker to predict kidney graft outcome.
Süsal C; Opelz G
Clin Chim Acta; 2012 Sep; 413(17-18):1350-3. PubMed ID: 22037199
[TBL] [Abstract][Full Text] [Related]
68. Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation.
Lee KW; Kim SJ; Lee DS; Lee HH; Joh JW; Lee SK; Oh HY; Kim DJ; Kim YG; Huh WS; Oh WI; Lee BB
Transplant Proc; 2004 Sep; 36(7):2009-10. PubMed ID: 15518726
[TBL] [Abstract][Full Text] [Related]
69. Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.
Fernández-Ruiz M; Parra P; López-Medrano F; Ruiz-Merlo T; González E; Polanco N; Origüen J; San Juan R; Andrés A; Aguado JM
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28122147
[TBL] [Abstract][Full Text] [Related]
70. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
71. Posttransplant sCD30 as a predictor of kidney graft outcome.
Süsal C; Döhler B; Sadeghi M; Salmela KT; Weimer R; Zeier M; Opelz G
Transplantation; 2011 Jun; 91(12):1364-9. PubMed ID: 21505378
[TBL] [Abstract][Full Text] [Related]
72. Pretransplant soluble CD30 serum concentration does not affect kidney graft outcomes 3 years after transplantation.
Kovač J; Arnol M; Vidan Jeras B; Bren AF; Kandus A
Transplant Proc; 2010 Dec; 42(10):4043-6. PubMed ID: 21168622
[TBL] [Abstract][Full Text] [Related]
73. Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis.
Mirzakhani M; Shahbazi M; Akbari R; Dedinská I; Nemati E; Mohammadnia-Afrouzi M
Front Immunol; 2020; 11():295. PubMed ID: 32256486
[TBL] [Abstract][Full Text] [Related]
74. Age-dependent changes of serum soluble CD30 concentration in children.
Chrul S; Polakowska E
Pediatr Transplant; 2011 Aug; 15(5):515-8. PubMed ID: 21672104
[TBL] [Abstract][Full Text] [Related]
75. B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients.
Rossano JW; Denfield SW; Kim JJ; Price JF; Jefferies JL; Decker JA; Smith EO; Clunie SK; Towbin JA; Dreyer WJ
J Heart Lung Transplant; 2008 Jun; 27(6):649-54. PubMed ID: 18503965
[TBL] [Abstract][Full Text] [Related]
76. HLA class I (ABC) upregulation on peripheral blood CD3+/CD8+ T lymphocyte surface is a potential predictor of acute rejection in renal transplantation.
Tian J; Shi WF; Zhang LW; Lu N; Cui XQ; Xian WH; Sun HB; Li EG; Geng LN; Zhang DZ; Zou X
Transplantation; 2009 Dec; 88(12):1393-7. PubMed ID: 20029336
[TBL] [Abstract][Full Text] [Related]
77. Diagnostic Performance of Fas Ligand mRNA Expression for Acute Rejection after Kidney Transplantation: A Systematic Review and Meta-Analysis.
Heng B; Ding H; Ren H; Shi L; Chen J; Wu X; Lai C; Yu G; Xu Y; Su Z
PLoS One; 2016; 11(11):e0165628. PubMed ID: 27812144
[TBL] [Abstract][Full Text] [Related]
78. Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation.
Frisaldi E; Conca R; Magistroni P; Fasano ME; Mazzola G; Patanè F; Zingarelli E; Dall'omo AM; Brusco A; Amoroso A
Transplantation; 2006 Apr; 81(8):1153-6. PubMed ID: 16641601
[TBL] [Abstract][Full Text] [Related]
79. Value of pretransplantation cytokine profiles for predicting acute rejection in renal transplant recipients.
Lessan-Pezeshki M; Amirzargar A; Fathi A; Khatami MR; Einollahi B; Pourfarziani V; Azmandian J; Khosravi F; Ansaripour B; Nikbin B
Transplant Proc; 2005 Sep; 37(7):2982-4. PubMed ID: 16213280
[TBL] [Abstract][Full Text] [Related]
80. Soluble CD30 serum level--an adequate marker for allograft rejection of solid organs?
Schlaf G; Altermann WW; Rothhoff A; Seliger B
Histol Histopathol; 2007 Nov; 22(11):1269-79. PubMed ID: 17647199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
